Similar articles

• [Genetic testing in patients at risk for carcinoma of the breast].

  Kiechle M. Kiechle M. Dtsch Med Wochenschr. 2006 Oct 27;131(43):2420-2. doi: 10.1055/s-2006-955026. Dtsch Med Wochenschr. 2006. PMID: 17054060 German. No abstract available.
• Who should be screened for hereditary breast cancer and what should be done with the information?

  Saade M, Salamoun W, Tueni E, Shami PJ. Saade M, et al. J Med Liban. 1999 Sep-Oct;47(5):281-3. J Med Liban. 1999. PMID: 10887526 No abstract available.
• "First do no harm" also applies to cancer susceptibility testing.

  Burke W, Kahn MJ, Garber JE, Collins FS. Burke W, et al. Cancer J Sci Am. 1996 Sep-Oct;2(5):250-2. Cancer J Sci Am. 1996. PMID: 9166540 No abstract available.
• Clinical implications of genetic testing for inherited breast and ovarian cancer risk.

  Calzone KA. Calzone KA. Nurs Spectr (Wash D C). 1998 Nov 16;8(23):12-4. Nurs Spectr (Wash D C). 1998. PMID: 10542772 Review. No abstract available.
• Breast cancer susceptibility testing: past, present and future.

  Goldberg JI, Borgen PI. Goldberg JI, et al. Expert Rev Anticancer Ther. 2006 Aug;6(8):1205-14. doi: 10.1586/14737140.6.8.1205. Expert Rev Anticancer Ther. 2006. PMID: 16925486 Review.